Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Methylprednisolone for High-Risk COVID-19
NCT04355247Phase 2Unknown
- Sponsor
- Auxilio Mutuo Cancer Center
- Start
- Apr 2020
- Primary completion
- Jul 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methylprednisolone injection in coronavirus disease 2019 (COVID-19), sponsored by Auxilio Mutuo Cancer Center. Status: unknown.
02
Drugs
methylprednisolone injection
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04355247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04355247.